| Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia JE Megías-Vericat, P Montesinos, MJ Herrero, F Moscardó, V Bosó, ... Leukemia & lymphoma 58 (5), 1197-1206, 2017 | 44 | 2017 |
| DNA delivery to ‘ex vivo’human liver segments MJ Herrero, L Sabater, G Guenechea, L Sendra, AI Montilla, R Abargues, ... Gene therapy 19 (5), 504-512, 2012 | 33 | 2012 |
| Translational advances of hydrofection by hydrodynamic injection L Sendra, MJ Herrero, SF Aliño Genes 9 (3), 136, 2018 | 30 | 2018 |
| Comparative antitumor effect among GM-CSF, IL-12 and GM-CSF+ IL-12 genetically modified tumor cell vaccines A Miguel, MJ Herrero, L Sendra, R Botella, R Algás, M Sánchez, SF Aliño Cancer Gene Therapy 20 (10), 576-581, 2013 | 26 | 2013 |
| Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy JE Megías-Vericat, P Montesinos, MJ Herrero, F Moscardó, V Bosó, ... The Pharmacogenomics Journal 18 (2), 301-307, 2018 | 24 | 2018 |
| Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment JE Megías-Vericat, P Montesinos, MJ Herrero, F Moscardó, V Bosó, ... Leukemia & lymphoma 58 (12), 2880-2894, 2017 | 24 | 2017 |
| Progress in the use of antisense oligonucleotides for vaccine improvement A Batista-Duharte, L Sendra, MJ Herrero, D Téllez-Martínez, IZ Carlos, ... Biomolecules 10 (2), 316, 2020 | 22 | 2020 |
| Mitochondrial DNA replacement techniques to prevent human mitochondrial diseases L Sendra, A García-Mares, MJ Herrero, SF Aliño International journal of molecular sciences 22 (2), 551, 2021 | 19 | 2021 |
| Pharmacogenetics implementation in the clinics: information and guidelines for germline variants G Olivera, L Sendra, MJ Herrero, P Berlanga, P Gargallo, Y Yáñez, ... Cancer Drug Resistance 2 (1), 53, 2019 | 19 | 2019 |
| Silencing of Foxp3 enhances the antitumor efficacy of GM-CSF genetically modified tumor cell vaccine against B16 melanoma A Miguel, L Sendra, V Noé, CJ Ciudad, F Dasí, D Hervas, MJ Herrero, ... OncoTargets and therapy, 503-514, 2017 | 19 | 2017 |
| Studying Closed Hydrodynamic Models of “In Vivo” DNA Perfusion in Pig Liver for Gene Therapy Translation to Humans L Sendra, A Miguel, D Pérez-Enguix, MJ Herrero, E Montalvá, ... PLoS One 11 (10), e0163898, 2016 | 19 | 2016 |
| Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation I Sánchez-Lázaro, MJ Herrero, C Jordán-De Luna, V Bosó, L Almenar, ... Pharmacogenomics 16 (9), 971-979, 2015 | 19 | 2015 |
| Physical methods of gene delivery MJ Herrero, L Sendra, A Miguel, SF Aliño Safety and Efficacy of Gene-Based Therapeutics for Inherited Disorders, 113-135, 2017 | 18 | 2017 |
| Low RNA translation activit limits the efficacy of hydrodynamic gene transfer to pig liver in vivo L Sendra, O Carreño, A Miguel, E Montalvá, MJ Herrero, F Orbis, ... The journal of gene medicine 16 (7-8), 179-192, 2014 | 16 | 2014 |
| Efficacy of hydrodynamic interleukin 10 gene transfer in human liver segments with interest in transplantation L Sendra Gisbert, A Miguel Matas, L Sabater Orti, MJ Herrero, ... Liver Transplantation 23 (1), 50-62, 2017 | 15 | 2017 |
| A surgical model for isolating the pig liver in vivo for gene therapy O Carreño, L Sendra, E Montalvá, A Miguel, F Orbis, MJ Herrero, ... European Surgical Research 51 (1-2), 47-57, 2013 | 15 | 2013 |
| Ciudad CJ, Dasí F A Miguel, L Sendra, V Noé Hervas D., Herrero MJ, Aliño SF Silencing of Foxp3 enhances the antitumor …, 2017 | 12 | 2017 |
| Gold nanoparticle-assisted virus formation by means of the delivery of an oncolytic adenovirus genome L Sendra, A Miguel, MC Navarro-Plaza, MJ Herrero, J de la Higuera, ... Nanomaterials 10 (6), 1183, 2020 | 10 | 2020 |
| Human AAT gene transfer to pig liver improved by using a perfusion isolated organ endovascular procedure L Sendra, D Pérez, A Miguel, MJ Herrero, I Noguera, A Díaz, D Barettino, ... European radiology 26, 95-102, 2016 | 10 | 2016 |
| Comparative Antitumor Effect of Preventive versus Therapeutic Vaccines Employing B16 Melanoma Cells Genetically Modified to Express GM-CSF and B7.2 in a … A Miguel, MJ Herrero, L Sendra, R Botella, R Algás, M Sánchez, SF Aliño Toxins 4 (11), 1058-1081, 2012 | 10 | 2012 |
